The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
State of the science on prevention and screening to reduce melanoma incidence and mortality: The time is now
Open accessAbstract
Answer questions and earn CME/CNE Although overall cancer incidence rates are decreasing, melanoma incidence rates continue to increase about 3% annually. Melanoma is a significant public health problem that exacts a substantial financial burden. Years of potential life lost from melanoma deaths contribute to the social, economic, and human toll of this disease. However, most cases are potentially preventable. Research has clearly established that exposure to ultraviolet radiation increases melanoma risk. Unprecedented antitumor activity and evolving survival benefit from novel targeted therapies and immunotherapies are now available for patients with unresectable and/or metastatic melanoma. Still, prevention (minimizing sun exposure that may result in tanned or sunburned skin and avoiding indoor tanning) and early detection (identifying lesions before they become invasive or at an earlier stage) have significant potential to reduce melanoma incidence and melanoma‐associated deaths. This article reviews the state of the science on prevention and early detection of melanoma and current areas of scientific uncertainty and ongoing debate. The US Surgeon General's Call to Action to Prevent Skin Cancer and US Preventive Services Task Force reviews on skin cancer have propelled a national discussion on melanoma prevention and screening that makes this an extraordinary and exciting time for diverse disciplines in multiple sectors—health care, government, education, business, advocacy, and community—to coordinate efforts and leverage existing knowledge to make major strides in reducing the public health burden of melanoma in the United States. CA Cancer J Clin 2016;66:460–480. © 2016 American Cancer Society .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J. J., Cowey, C. L., Lao, C. D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504030 · Cited by 8,157
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Self-citationCombined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Self-citationA review of human carcinogens--part D: radiation
El Ghissassi, F., Baan, R., Straif, K., Grosse, Y., Secretan, B., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70213-x · Cited by 900
Reduced melanoma after regular sunscreen use: randomized trial follow-up
Green, A. C., Williams, G. M., Logan, V., & Strutton, G. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7078 · Cited by 799
The International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer (2007) · International Journal of Cancer · doi:10.1002/ijc.22453 · Cited by 561
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006
Jemal, A., Saraiya, M., Patel, P., Cherala, S. S., Barnholtz-Sloan, J., Kim, J., Wiggins, C. L., & Wingo, P. A. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.032 · Cited by 385
Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis
Dennis, L. K., Vanbeek, M. J., Beane Freeman, L. E., Smith, B. J., Dawson, D. V., & Coughlin, J. A. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2008.04.006 · Cited by 370 · cited 1×
“ful and other studies showing that sunburn during any life period raises risk.(45,46) Scientific evidence links indoor tan-”
Indoor Tanning and Risk of Melanoma: A Case-Control Study in a Highly Exposed Population
Lazovich, D., Vogel, R. I., Berwick, M., Weinstock, M. A., Anderson, K. E., & Warshaw, E. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1249 · Cited by 353 · cited 1×
“A Minnesota case-control study of indoor tanning and melanoma risk revealed that risk increased with the number of years, hours, and sessions of indoor tanning and that it increased independent of outdoor exposure.(93) An Australian population-based, casecontrol study of early onset melanoma showed that ever using a s…”
Skin β-Endorphin Mediates Addiction to UV Light
Fell, G. L., Robinson, K. C., Mao, J., Woolf, C. J., & Fisher, D. E. (2014) · Cell · doi:10.1016/j.cell.2014.04.032 · Cited by 299
Anatomic Site, Sun Exposure, and Risk of Cutaneous Melanoma
Whiteman, D. C., Stickley, M., Watt, P., Hughes, M. C., Davis, M. B., & Green, A. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1325 · Cited by 210 · cited 1×
“whereas recreational exposures were associated with melanomas of the trunk.(59)”
Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners
Feldman, S. R., Liguori, A., Kucenic, M., Rapp, S. R., Fleischer, A. B., Lang, W., & Kaur, M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.01.053 · Cited by 179
Cokkinides, V., Weinstock, M., Glanz, K., Albano, J., Ward, E., & Thun, M. (2006) · Pediatrics · doi:10.1542/peds.2005-3109 · Cited by 160
Teledermatology: Key factors associated with reducing face-to-face dermatology visits
Landow, S. M., Mateus, A., Korgavkar, K., Nightingale, D., & Weinstock, M. A. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.02.021 · Cited by 131
Indoor tanning and risk of early-onset basal cell carcinoma
Ferrucci, L. M., Cartmel, B., Molinaro, A. M., Leffell, D. J., Bale, A. E., & Mayne, S. T. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.11.940 · Cited by 107
Harrington, C. R., Beswick, T. C., Graves, M., Jacobe, H. T., Harris, T. S., Kourosh, S., Devous Sr, M. D., & Adinoff, B. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00312.x · Cited by 81
Counseling parents and children on sun protection: a national survey of pediatricians
Balk, S. J., O’Connor, K. G., & Saraiya, M. (2004) · Pediatrics · doi:10.1542/peds.2004-1305 · Cited by 59
Self-citation
Cited by
Keung, E. Z., & Gershenwald, J. E. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1489246 · Cited by 593
Self-citationMolecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases
Fischer, G. M., Jalali, A., Kircher, D. A., Lee, W.-C., McQuade, J. L., Haydu, L. E., Joon, A. Y., Reuben, A., de Macedo, M. P., Carapeto, F. C. L., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1489 · Cited by 329
Self-citationSusceptibility and Resistance Mechanisms During Photodynamic Therapy of Melanoma
Li, X.-Y., Tan, L.-C., Dong, L.-W., Zhang, W.-Q., Shen, X.-X., Lu, X., Zheng, H., & Lu, Y.-G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00597 · Cited by 55
Metadata
- Authors
- Tripp, M. K., Watson, M., Balk, S. J., Swetter, S. M., & Gershenwald, J. E.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2016-05-27
- Volume
- 66
- Issue
- 6
- Pages
- 460-480
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2405976160
- Cited by
- 184
- References
- 21
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.